Login

Introducing YESCan: Streamlining Fenestration Product Data Submission to NRCan | Valmor Ruscheck - CEO of Natural Resources Canada 00:10:00

Share On Facebook Share On Twitter

Valmor Ruscheck is the CEO of Natural Resources Canada

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Exceptional products that exceed our clients’ expectations|Yasuhiro Yokota,President,Tokio Marine Asset Management (USA) Ltd.
00:10:00
CEO Andreas Thorsheim presents Otovo, a Norwegian startup offering a residential solar and battery marketplace, at Ecosummit Berlin 2023.
00:10:00
Market Intelligence: Emerging Trends in the Fintech Sector | John Doerr, Chairman,  Kleiner Perkins.
00:10:00
United Utilities CEO Louise Bedmore on Enhancing Regional Sustainability and Infrastructure | Louise Beardmore, CEO, United Utilities Group PLC.
00:10:00
Lions Talk: Final Test Predictions with Shane Williams & Andy Nicol
00:10:00
Amex Exploration (TSXV-AMX; OTCQX-AMXEF) has seen a 50%+ move higher in its share price from its Fall, 2023 bottom: a looming resource estimate that will quite possibly establish|VICTOR CANTORE,CEO,Amex Exploration (IE)
00:00:00
Christopher U. Missling, PhD, President & CEO of Anavex Life Sciences Corp.
00:10:00
Azure Minerals' Andover Lithium Project: A Transformative Year with Major Discoveries and Takeover Offer
00:10:00
BIO-key's Periodic SEC Filings Offer Comprehensive Insights into Cybersecurity Expansion and Business Performance | Michael DePasquale, CEO, BIO-key International Inc.
00:10:00
selling focused on publicly traded frauds and promotes.|Kir Kahlon,CIO,Scorpion Capital Partners
00:10:00
Andy elaborates on Capita's digital transformation approach, directing viewers to their website and LinkedIn page for further information.
00:10:00
Basil Karampelas discusses ClearVue Technologies Ltd.'s vision and progress in an interview with The Market Herald.

© 2017 - Neuhu+